anmelden
OMX Nordic 40
2.715,53
PKT
-2,53
PKT
-0,09
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.06.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 30.06.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 30.06.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 29.06.23 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 29.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 29.06.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 29.06.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 29.06.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 29.06.23 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 29.06.23 | Nokia Overweight | JP Morgan Chase & Co. | |
| 28.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.06.23 | Nokia Equal Weight | Barclays Capital | |
| 28.06.23 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 27.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 27.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Sell | UBS AG | |
| 26.06.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 20.06.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 20.06.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.06.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 19.06.23 | AstraZeneca Neutral | UBS AG | |
| 19.06.23 | Novo Nordisk Sell | UBS AG | |
| 19.06.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 16.06.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 16.06.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 16.06.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 15.06.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 15.06.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 15.06.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 15.06.23 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 15.06.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 12.06.23 | Novo Nordisk Sell | UBS AG | |
| 12.06.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.06.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 09.06.23 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 08.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.06.23 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 05.06.23 | AstraZeneca Neutral | UBS AG |
